This study investigated apoptosis in prostate cancer before and after neoadjuvant treatment with LH-RH analog, demonstrating that this therapy induced high AI and bax and survivin overexpression; thus acting as a proapoptotic agent in prostate cancer. A statistically significant correlation was found between high AI and overexpression of bax protein after therapy. It is probable that this kind of therapy is deeply implicated in promoting the apoptotic intrinsic pathway.

Apoptosis in prostate carcinoma before and after neoadjuvant therapy with LH-RH analog / S., Bencini; Migaldi, Mario; G., Castagnetti; Pincelli, Carlo; P., Ferrari; DE GAETANI, Carmela; G. P., Trentini. - In: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. - ISSN 0077-8923. - STAMPA. - 1010:(2003), pp. 789-792.

Apoptosis in prostate carcinoma before and after neoadjuvant therapy with LH-RH analog

MIGALDI, Mario;PINCELLI, Carlo;DE GAETANI, Carmela;
2003

Abstract

This study investigated apoptosis in prostate cancer before and after neoadjuvant treatment with LH-RH analog, demonstrating that this therapy induced high AI and bax and survivin overexpression; thus acting as a proapoptotic agent in prostate cancer. A statistically significant correlation was found between high AI and overexpression of bax protein after therapy. It is probable that this kind of therapy is deeply implicated in promoting the apoptotic intrinsic pathway.
1010
789
792
Apoptosis in prostate carcinoma before and after neoadjuvant therapy with LH-RH analog / S., Bencini; Migaldi, Mario; G., Castagnetti; Pincelli, Carlo; P., Ferrari; DE GAETANI, Carmela; G. P., Trentini. - In: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. - ISSN 0077-8923. - STAMPA. - 1010:(2003), pp. 789-792.
S., Bencini; Migaldi, Mario; G., Castagnetti; Pincelli, Carlo; P., Ferrari; DE GAETANI, Carmela; G. P., Trentini
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/592610
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact